AKYILDIZ, A. Et Al. 2024. Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG). EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9 , 4991-4999.

AKYILDIZ, A., GÜVEN, D. C., KÖKSAL, B., KARAOĞLAN, B. B., Kivrak, D., Ismayilov, R., ... Aslan, F.(2024). Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG). EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9, 4991-4999.

AKYILDIZ, ARİF Et Al. "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)," EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9, 4991-4999, 2024

AKYILDIZ, ARİF Et Al. "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)." EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9, pp.4991-4999, 2024

AKYILDIZ, A. Et Al. (2024) . "Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)." EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.281, no.9, pp.4991-4999.

@article{article, author={ARİF AKYILDIZ Et Al. }, title={Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)}, journal={EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY}, year=2024, pages={4991-4999} }